In contrast, non-mutated, wild type (wt) sequence peptides derived from genetically altered p53 molecules in tumors have a greater potential of being processed and presented and represent a more practical approach for developing broadly applicable p53-based cancer vaccines for the prevention and treatment of HNSCC5,6. Here, TP53 is linked to cancer.